MIRA INFORM REPORT

 

 

Report No. :

331872

Report Date :

14.07.2015

 

IDENTIFICATION DETAILS

 

Name :

USV LIMITED

 

 

Formerly Known As :

U.S. VITAMIN AND PHARMACEUTICAL CORPORATION (INDIA) PRIVATE LIMITED

 

 

Registered Office :

Arvind Vithal Gandhi Chowk, BSD Marg, Govandi, Mumbai - 400088, Maharashtra

Tel. No.:

91-22-25564048

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

25.08.1961

 

 

Com. Reg. No.:

11-012098

 

 

Capital Investment / Paid-up Capital :

Rs.999.669 Million

 

 

CIN No.:

[Company Identification No.]

U24239MH1961PLC012098

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMU00007A

 

 

PAN No.:

[Permanent Account No.]

AAACU1366N

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

The Company is engaged in the manufacturing and selling of Active Pharmaceutical Ingredient (API), finished dosages and generics.

 

 

No. of Employees :

Information declined by the management.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A (68)

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

USV is a leading healthcare company with focus on branded generics APIs, and bio-similars. Company was incorporated on 25th August 1961, and is an old and well established company having good track record.

 

The ratings on USC Limited continue to reflect its strong financial risk profile, marked by healthy operating profitability, negligible debt, and strong liquidity.

 

The rating continues to drive strength on USV’s robust market position, long track record of its business and rich experienced of the promoters in the pharmaceutical business.

 

These rating strengths are partially offset by the high product concentration in the company’s revenue profile, and competition from domestic as well as foreign players.

 

Trade relation reported to be fair. Business is active. Payment terms are reported to be regular and as per commitment.

 

The company can be considered good for normal business dealing at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long term rating AA+

Rating Explanation

High degree of safety and very low credit risk.

Date

14.10.2014

 

 

Rating Agency Name

CRISIL

Rating

Short term rating A1+

Rating Explanation

Very strong degree at safety and lowest credit risk.

Date

14.10.2014

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2013.

 

INFORMATION DENIED

 

Management non co-operative

 

Contact No.: 91-22-25564048

 

LOCATIONS

 

Registered / Corporate Office :

Arvind Vithal Gandhi Chowk, BSD Marg, Govandi, Mumbai - 400088, Maharashtra, India

Tel. No.:

91-22-25564048/ 4049/ 4050/ 4051/ 2225/ 25559915/ 25581118/ 67861111

Fax No.:

91-22-25515608/ 25584025

E-Mail :

albert.matherus@usv.co.in

sudhir.thatte@usv.co.in

hrd@usv.co.in

info@usv.co.in

info@usvlimitedindia.com

hrd@usv.co.in

custompeptides@usv.co.in

bizdev@usv.co.in

Website :

http://www.usvindia.com

Location :

Owned

 

 

Factory 1 :

MIDC, Lote Industrial Area, Khed, Ratnagiri, OIDC, Dabhel, Daman, HPSIDC, Baddi, Himachal Pradesh, India

 

 

Factory 2 :

Plot No. B-1 / 8, M.I.D.C. Lote Industrial Area, Taluka Khed, Ratnagiri, Maharashtra, India

Tel. No.:

91-2356-272242

Fax No.:

91-2356-272402

 

 

Factory 3:

OIDC, Dabhel, Daman, Daman and Diu, India

 

 

Factory 4:

Hilltop Industrial, Area, Jhar Majri, Baddi, Himachal Pradesh, India

 

 

DIRECTORS

 

AS ON 12.09.2014

 

Name :

Mrs. Leena Gandhi Tewari

Designation :

Director

Address :

41, Ritu Apartments, 208, B.J. Road, Bandra (West), Mumbai-400050, Maharashtra, India

Date of Birth/Age :

09.03.1957

Qualification :

MBA, Boston University, USA B. Com.

Date of Appointment :

20.01.1986

DIN No.:

00001748

 

 

Name :

Mr. Prashant Kumar Tewari

Designation :

Managing director

Address :

41, Ritu Apartments, 208, B J Road, Bandra ( West), Mumbai-400050, Maharashtra, India

Date of Birth/Age :

09.04.1958

Qualification :

MS, B. Tech IIT- Kanpur

Date of Appointment :

01.05.2013

DIN No.:

00001745

 

 

Name :

Debabrata Sujit Gupta

Designation :

Whole-time director Executive Director & Chief Operating Officer

Address :

B-804, Etrnai, Hiranandani Gardens, Powai, Mumbai - 400076, Maharashtra, India

Date of Birth/Age :

19.02.1963

Qualification :

B. Tech.(Chemistry)-IIT Kharagpur

Date of Appointment :

19.09.2008

DIN No.:

01500784

 

 

Name :

Mr. Deepak Keshav Ghaisas

Designation :

Director

Address :

B 61/62, Swapnashilp Apartments, Mahant Road, Vile Parle (East), Mumbai-400057, Maharashtra, India

Date of Birth/Age :

19.11.1957

Qualification :

CA, CS and ICWA

Date of Appointment :

12.09.2014

DIN No.:

00001811

 

 

Name :

Mr. Debabrata Bhadury

Designation :

Director

Address :

9-A, Belvedere Court, Sane Guruji Marg, Mahalaxmi, Mumbai - 400011, Maharashtra, India

Date of Birth/Age :

20.11.1941

Qualification :

MA (Economics)

Date of Appointment :

01.05.2001

DIN No.:

00001754

 

 

Name :

Murugappan Muthiah Venkatachalam

Designation :

Director

Address :

20/1, Valliammai Achi Road, Kottupuram, Chennai - 600085, Tamilnadu, India

Date of Birth/Age :

24.11.1958

Qualification :

MBA, Washington University, USA

Date of Appointment :

12.09.2014

DIN No.:

00152619

 

 

Name :

Mr. Vilas Gandhi Tewari

Designation :

Director

Address :

5416, Fair Ave Apartment, 1321, N Hollywood, CA USA 91601

Date of Birth/Age :

24.03.1984

Date of Appointment :

27.09.2012

DIN No.:

05354249

 

 

Name :

Krishnakumar Maheshwari

Designation :

Director

Address :

903, Palmyra Skuline Oasis Apartment, Premier Road, Vidyavihar, Mumbai – 400086, Maharashtra, India

Date of Birth/Age :

01.05.1940

Date of Appointment :

12.09.2014

Date of Cessation :

11.02.2015

DIN No.:

06895677

 

 

 

 

 

 

KEY EXECUTIVES

 

Name :

Mr. Anil Bhalchandra Kale

Designation :

Secretary

Address :

703, Susheela Apartment CHS, Kaka Sohoni Marg, Thane – 400601, Maharashtra, India

Date of Birth/Age :

20.01.1983

Date of Appointment :

11.02.2013

PAN No.:

AALPK2653C

 

 

Name :

Prakash Chandrasekharan Menon

Designation :

CFO

Address :

703, Joanna I, 10,Manuel Gonsalves Road, Bandra West, Mumbai - 400050, Maharashtra, India

Date of Appointment :

18.06.2014

PAN No.:

AACPM8929L

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 12.09.2014

 

Names of Shareholders

 

No. of Shares

Leena Gandhi Tewari

91287618

Aneesha Gandhi Tewari

11106

Treva Health Care Private Limited, India

5553

Vipal Health Care Private Limited, India

5553

USV Reliable Homes Private Limited, India

7404

Leena Gandhi Tewari Jointly with Prashant Tewari

5395665

Prashant Tewari Jointly with Leena Gandhi Tewari

3041193

Prashant Tewari

201759

Neo-Pharma Industries Private Limited, India

11106

 

 

TOTAL

99966957

 

AS ON 12.09.2014

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage of Holding

Directors or relatives of Directors

100.00

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

The Company is engaged in the manufacturing and selling of Active Pharmaceutical Ingredient (API), finished dosages and generics.

 

 

Products :

ITC Code

Product Descriptions

21069099

Visyneral

21069091

Diataal

29331990

Irbesartan

29350090

Glimepiride

29420090

Metformin

30049099

Glycomet

30049099

Ecosprin

30045090

Bottles

30049099

Metformin

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Available

 

 

Imports :

Not Available

 

 

Terms :

Not Available

 

 

GENERAL INFORMATION

 

Supplier :

Not Available

 

 

Customer :

Not Available

 

 

No. of Employees :

Information declined by the management.

 

 

Bankers :

Ø  Axis Bank Limited, Trishul 3rd Floor Opposite Samartheshwar Temple, Law Garden Ellisbridge, Ahmedabad - 380006, Gujarat, India

Ø  Standard Chartered Grindlays Bank Limited, Dr. D. N. Road, Mumbai-400001, Maharashtra, India

Ø  State Bank of India

Ø  The Saraswat Co-operative Bank Limited

Ø  Deutsche Bank

Ø  Yes Bank Limited

 

Financial Institution :

Department of Biotechnology, Block 2, Cgo Complex, New Delhi - 110003, India

 

 

Auditors :

 

Name :

BSR and Associates

Chartered Accountants

Address :

Lodha Excelus, 1st Floor, Apollo Mills Compound, NM Marg, Mahalaxmi, Mumbai 400011, Maharasthra, India

PAN No. :

AADFB6889R

 

 

Internal Auditor :

 

Name :

A P R Associates

Chartered Accountants

 

 

Cost Auditor :

 

Name :

Sevekari, Khare and Associates

Cost Accountants

 

 

Subsidiaries Company :

  • Bharavi Laboratories Private Limited [U24119KA1996PTC020463]
  • Indicus Pharma LLC
  • USV Europe Limited
  • USV North America, Inc.
  • USV Labs Limited [U24232MH2010PLC205370]

 

 

Enterprises which are owned, or have significant

influence of or are partners

with Key management personnel and their relatives :

  • Neo-Pharma Industries Private Limited [U24239MH1960PTC011862]
  • Treva Health Care Private Limited [U24239MH1989PTC054400]
  • USV Reliable Homes Private Limited [U24239MH1995PTC092234]
  • V. B. Gandhi and Company
  • Vipal Health Care Private Limited [U24239MH1989PTC054414]

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

125000000

Equity Shares

Rs.10/- each

Rs.1250.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

99966957

Equity Shares

Rs.10/- each

Rs.999.669 Million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

999.669

999.669

999.669

(b) Reserves & Surplus

13770.413

11505.741

9772.418

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.0000

0.000

Total Shareholders’ Funds (1) + (2)

14770.082

12505.410

10772.087

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

4.919

8.799

19.765

(b) Deferred tax liabilities (Net)

244.283

178.549

121.089

(c) Other long term liabilities

0.000

0.000

59.876

(d) long-term provisions

28.836

32.866

709.438

Total Non-current Liabilities (3)

278.038

220.214

910.168

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.000

0.000

0.000

(b) Trade payables

1921.402

1659.634

1748.827

(c) Other current liabilities

695.397

601.079

492.920

(d) Short-term provisions

2533.789

2242.370

3079.537

Total Current Liabilities (4)

5150.588

4503.083

5321.284

 

 

 

 

TOTAL

20198.708

17228.707

17003.539

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

3840.159

3668.004

3392.032

(ii) Intangible Assets

91.432

98.512

110.773

(iii) Capital work-in-progress

93.707

511.061

591.331

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

13.091

2.297

2.297

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

1822.713

1199.477

1285.932

(e) Other Non-current assets

0.664

176.996

202.931

Total Non-Current Assets

5861.766

5656.347

5585.296

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

8822.856

6764.416

6105.423

(b) Inventories

1804.786

1625.971

1493.139

(c) Trade receivables

1921.481

1739.086

1477.302

(d) Cash and cash equivalents

958.776

722.904

404.677

(e) Short-term loans and advances

829.043

719.983

1511.397

(f) Other current assets

0.000

0.000

426.305

Total Current Assets

14336.942

11572.360

11418.243

 

 

 

 

TOTAL

20198.708

17228.707

17003.539

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

 

Income

18914.023

16888.835

14472.621

 

 

Other Income

1077.102

594.029

642.243

 

 

TOTAL                                    

19991.125

17482.864

15114.864

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of materials consumed

3651.931

3523.216

3195.140

 

 

Purchases of stock-in-trade

2866.189

2412.336

1991.741

 

 

Changes in inventories of finished goods, work-in-progress and stock-in-trade

(137.680)

(63.152)

(72.008)

 

 

Employee benefit expense

1921.931

1547.321

1477.249

 

 

Other expenses

5548.061

5255.543

4506.182

 

 

TOTAL                                    

13850.432

12675.264

11098.304

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

6140.693

4807.600

4016.560

 

 

 

 

 

Less

FINANCIAL EXPENSES                                   

0.023

0.065

0.239

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

6140.670

4807.535

4016.321

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

685.461

725.556

639.566

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

5455.209

4081.979

3376.755

 

 

 

 

 

Less

TAX                                                     

672.430

375.772

552.106

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

4782.779

3706.207

2824.649

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

F.O.B. Value of Exports

3989.000

 3665.120

3374.622 

 

TOTAL EARNINGS

3989.000

 3665.120

3374.622 

 

 

 

 

 

 

IMPORTS

 

 

 

 

Raw Materials

 1219.964

1082.406

1028.828

 

Components and Stores parts

 136.009

143.797

148.678

 

Capital Goods

 48.776

279.051

89.443

 

TOTAL IMPORTS

1404.749

1505.254

1266.948

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

47.84

37.07

28.26

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

PARTICULARS

 

31.03.2014

31.03.2013

 

31.03.2012

Current Maturities of Long term debt

3.879

10.966

6.053

Cash generated from operations

NA

NA

NA

Net cash flows from (used in) operations

5153.124

3919.325

3847.411

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

 

31.03.2012

Net Profit Margin
(PAT / Sales)

(%)

25.29

21.94

19.52

 

 

 

 

 

Operating Profit Margin
(PBIDT/Sales)

(%)

32.47

28.47

27.75

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

27.15

24.42

20.58

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.37

0.33

0.31

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.00

0.00

0.00

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.78

2.57

2.15

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

 

DEBT EQUITY RATIO

 

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

999.669

999.669

999.669

Reserves & Surplus

9772.418

11505.741

13770.413

Share Application money pending allotment

0.000

0.000

0.000

Net worth

10772.087

12505.410

14770.082

 

 

 

 

long-term borrowings

19.765

8.799

4.919

Short term borrowings

0.000

0.000

0.000

Current Maturities of Long Term Debt

6.053

10.966

3.879

Total borrowings

25.818

19.765

8.798

Debt/Equity ratio

0.002

0.002

0.001

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

14472.621

16888.835

18914.023

 

 

16.695

11.991

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

14472.621

16888.835

18914.023

Profit

2824.649

3706.207

4782.779

 

19.52%

21.94%

25.29%

 

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

---

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

No

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

No

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

Yes

32

Litigations that the firm/promoter involved in

---

33

Market information

---

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 

 

 

UNSECURED LOANS   

 

PARTICULARS

31.03.2014

(Rs. in Million)

31.03.2013

(Rs. in Million)

LONG TERM BORROWINGS

 

 

Deferred payment liabilities

[Deferred sales tax loan is interest free and is payable in spread of 5 equal installments after completion of 10 years]

4.919

8.799

Total

4.919

8.799

 

 

INDEX OF CHARGES : NO CHARGES EXIST FOR COMPANY

 

 

CORPORATE INFORMATION

 

The company is a public company domiciled in India and incorporated under the provision of the Companies Act, 1956. Its shares are not listed on any stock exchange in India. The Company is engaged in the manufacturing and selling of Active Pharmaceutical Ingredient (API), finished dosages and generics. The Company is admired in India for leadership in diabetes and cardio-vascular space, as well as strong brands in other segments.

 

 

FIXED ASSETS

 

  • Land – Freehold
  • Land – Leasehold
  • Factory Building
  • Residential Buildings
  • Office Premises
  • Plant and Machinery
  • Office Equipments
  • Furniture and Fixtures
  • Vehicles
  • Computers

 

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.63.47

UK Pound

1

Rs.98.47

Euro

1

Rs.70.69

 

 

INFORMATION DETAILS

 

Information Gathered by :

KMN

 

 

Analysis Done by :

KAS

 

 

Report Prepared by :

SNT

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

8

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

7

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

8

--PROFITABILIRY

1~10

8

--LIQUIDITY

1~10

8

--LEVERAGE

1~10

8

--RESERVES

1~10

7

--CREDIT LINES

1~10

8

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

68

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.